Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients. (Q50656673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

1 reference

Adriana Carol Eleonora Graziano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Giovanna Pannuzzo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Anna Sara Berardi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Elvira Costantino-Ceccarini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Paola Piomboni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Alice Luddi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

23 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

294-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24913062%20AND%20SRC:MED&resulttype=core&format=json

Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Chemical pathology of Krabbe's disease. III. Ceramide-hexosides and gangliosides of brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Leukodystrophies: classification, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

The inherited leukodystrophies: a clinical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Molecular heterogeneity of Krabbe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Retrovirus-mediated gene transfer and galactocerebrosidase uptake into twitcher glial cells results in appropriate localization and phenotype correction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-D- galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

The fluorimetric determination of beta-glucosidase: its occurrence in the tissues of animals, including insects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Determination of Acid β-Galactosidase Activity: Methodology and Perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Fabry disease: enzymatic diagnosis in dried blood spots on filter paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Basic local alignment search tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Validation of the 53A6 GROMOS force field

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Automated docking with protein flexibility in the design of femtomolar "click chemistry" inhibitors of acetylcholinesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

FOXL2 in human endometrium: hyperexpressed in endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Insights into Krabbe disease from structures of galactocerebrosidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

A high-throughput screening assay using Krabbe disease patient cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

New strategies for the treatment of lysosomal storage diseases (review).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Concurrent measurement of unbound genistein in the blood, brain and bile of anesthetized rats using microdialysis and its pharmacokinetic application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009

The twitcher mouse: degeneration of oligodendrocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.05.009